|
Basis of Presentation and Significant Accounting Policies (Details) (USD $)
|
3 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Mar. 31, 2014
|
Mar. 31, 2013
|
Mar. 31, 2012
|
Mar. 31, 2014
Customer Concentration Risk [Member]
Customer
|
Mar. 31, 2013
Customer Concentration Risk [Member]
Customer
|
Dec. 31, 2013
Customer Concentration Risk [Member]
Customer
|
Mar. 31, 2014
Revenues [Member]
Customer Concentration Risk [Member]
Customer 1 [Member]
|
Mar. 31, 2013
Revenues [Member]
Customer Concentration Risk [Member]
Customer 1 [Member]
|
Mar. 31, 2014
Revenues [Member]
Customer Concentration Risk [Member]
Customer 2 [Member]
|
Mar. 31, 2013
Revenues [Member]
Customer Concentration Risk [Member]
Customer 2 [Member]
|
Mar. 31, 2014
Revenues [Member]
Customer Concentration Risk [Member]
Customer 3 [Member]
|
Mar. 31, 2014
Accounts Receivable [Member]
Customer Concentration Risk [Member]
Customer 1 [Member]
|
Dec. 31, 2013
Accounts Receivable [Member]
Customer Concentration Risk [Member]
Customer 1 [Member]
|
Mar. 31, 2014
Accounts Receivable [Member]
Customer Concentration Risk [Member]
Customer 2 [Member]
|
Dec. 31, 2013
Accounts Receivable [Member]
Customer Concentration Risk [Member]
Customer 2 [Member]
|
Mar. 31, 2014
Accounts Receivable [Member]
Customer Concentration Risk [Member]
Customer 3 [Member]
|
Mar. 31, 2014
Restate Previously Reported Diluted Loss per Share for March 2012 Warrants [Member]
|
Mar. 31, 2014
Restate Previously Reported Diluted Loss per Share for March 2012 Warrants [Member]
Restatement Adjustment [Member]
|
Mar. 31, 2014
Restate Previously Reported Diluted Loss per Share for March 2012 Warrants [Member]
Previously Reported [Member]
|
|
| Restatement [Abstract] | |||||||||||||||||||
| Term of warrants | 5 years | ||||||||||||||||||
| Aggregate number of unregistered shares of common stock called by warrants (in shares) | 14,834,577 | ||||||||||||||||||
| Exercise price of shares purchased under warrants (in dollars per share) | $ 1.76 | ||||||||||||||||||
| Impact of restatement on the reported diluted loss per share (in dollars per share) | $ (0.17) | ||||||||||||||||||
| Diluted net loss per share of common stock (in dollars per share) | $ (0.21) | $ (0.30) | $ (0.21) | $ (0.04) | |||||||||||||||
| Concentration Risk [Line Items] | |||||||||||||||||||
| Number of major customers | 3 | 2 | 2 | ||||||||||||||||
| Concentration risk, percentage (in hundredths) | 47.00% | 79.00% | 40.00% | 18.00% | 15.00% | 57.00% | 73.00% | 28.00% | 13.00% | 12.00% | |||||||||